Article Information
- Received April 19, 2007
- Revision received August 1, 2007
- Accepted August 2, 2007
- First published September 19, 2007.
- Version of record published September 19, 2007.
Author Information
- Laurent Groc2,
- Daniel Choquet2,
- F. Anne Stephenson3,
- Danièle Verrier1,
- Olivier J. Manzoni1, and
- Pascale Chavis1
- 1Inserm, Unité 862, Equipe Physiopathologie de la Plasticité Synaptique, 33077 Bordeaux Cedex, France,
- 2Physiologie Cellulaire de la Synapse, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5091, 33077 Bordeaux, France, and
- 3School of Pharmacy, University of London, London WC1N 1AX, United Kingdom
- Correspondence should be addressed to either of the following: Pascale Chavis, Inserm, Unité 862, 146 rue Leo Saignat, 33077 Bordeaux Cedex, France, chavis{at}bordeaux.inserm.fr; or Laurent Groc, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5091, 33077 Bordeaux Cedex, France, laurent.groc{at}u-bordeaux2.fr
Author contributions
Disclosures
- Received April 19, 2007.
- Revision received August 1, 2007.
- Accepted August 2, 2007.
-
This work was supported by Inserm (O.J.M., P.C.), Région Aquitaine (P.C., O.J.M., L.G., D.C.), Agence Nationale de la Recherche Grant 06-037-01 “Neurosciences, Neurologie et Psychiatrie” (P.C.), Centre National de la Recherche Scientifique (L.G., D.C.), Ministère de la Recherche (L.G., D.C.), Fondation pour la Recherche Médicale (L.G., D.C., P.C., O.J.M.), Association Française contre les Myopathies (L.G., D.C.), Human Frontier Science Program (L.G., D.C.), and European Community Grants QLG3-CT-2001-02089 and CT-2005-005320 (L.G., D.C.). We thank Dr. K. Nakajima (Keio University, Tokyo, Japan) for the CR-50 antibody, Dr. E. J. Weeber (Vanderbilt University, Nashville, TN) for recombinant Reelin, Dr. T. E. Willnow (Max Delbrück Center for Molecular Medicine, Berlin, Germany) for the expression construct of GST-tagged RAP, and Dr. J. Blahos (Prague, Czech Republic) for the expression of GST–RAP. We thank Dr. G. Westbrook for helpful discussions.
- Correspondence should be addressed to either of the following: Pascale Chavis, Inserm, Unité 862, 146 rue Leo Saignat, 33077 Bordeaux Cedex, France, chavis{at}bordeaux.inserm.fr; or Laurent Groc, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5091, 33077 Bordeaux Cedex, France, laurent.groc{at}u-bordeaux2.fr
Online Impact